Literature DB >> 30523672

Designing Multivalent Ligands to Control Biological Interactions: From Vaccines and Cellular Effectors to Targeted Drug Delivery.

Ammar Arsiwala1, Ana Castro1, Steven Frey1, Mark Stathos1, Ravi S Kane1.   

Abstract

Multivalent interactions in which multiple ligands on one object bind to multiple receptors on another are commonly found in natural biological systems. In addition, these interactions can lead to increased strength and selectivity when compared to the corresponding monovalent interaction. These attributes have also guided the design of synthetic multivalent ligands to control biological interactions. This review will highlight the recent literature describing the use of multivalent ligand display in the design of vaccines, immunomodulators, cell signaling effectors, and vehicles for targeted drug delivery.
© 2019 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.

Keywords:  cell signaling; immunomodulators; multivalency; targeted delivery; vaccines

Mesh:

Substances:

Year:  2019        PMID: 30523672     DOI: 10.1002/asia.201801677

Source DB:  PubMed          Journal:  Chem Asian J        ISSN: 1861-471X


  4 in total

1.  Heteroglycoclusters With Dual Nanomolar Affinities for the Lectins LecA and LecB From Pseudomonas aeruginosa.

Authors:  David Goyard; Baptiste Thomas; Emilie Gillon; Anne Imberty; Olivier Renaudet
Journal:  Front Chem       Date:  2019-10-02       Impact factor: 5.221

Review 2.  Nanoparticles and bioorthogonal chemistry joining forces for improved biomedical applications.

Authors:  Javier Idiago-López; Eduardo Moreno-Antolín; Jesús M de la Fuente; Raluca M Fratila
Journal:  Nanoscale Adv       Date:  2021-01-21

3.  The Synthesis and Evaluation of Multivalent Glycopeptoids as Inhibitors of the Adhesion of Candida albicans.

Authors:  Harlei Martin; Hannah Masterson; Kevin Kavanagh; Trinidad Velasco-Torrijos
Journal:  Pathogens       Date:  2021-05-08

Review 4.  Phage capsid nanoparticles as multivalent inhibitors of viral infections.

Authors:  Manzar Abbas; Muhammad Ovais; Chunying Chen
Journal:  Sci Bull (Beijing)       Date:  2020-09-15       Impact factor: 11.780

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.